Wolfgang Hulla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wolfgang Hulla has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Adelheid Woehrer
Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria
1 shared publication - Alexander Daxecker
Department of Medicine, Faculty of Medicine and Dentistry, Danube Private University, Krems, Austria
1 shared publication - Alexey Pryalukhin
Institute of Pathology, University Medical Centre Bonn, Bonn, Germany
1 shared publication - Andre Figueiredo Rendeiro
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
1 shared publication - Ernesto Abila
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14 AKH BT 25.3, 1090, Vienna, Austria
1 shared publication - Florian Heger
Institute for Microbiology, Austrian Agency for Health and Food Safety GmbH (AGES), Vienna, Austria
1 shared publication
Latest Publications
- 13 July 2026
- Published by Springer Nature in Wiener klinische Wochenschrift
- p. 1-5
Pulmonary tularemia leading to a relapse of tularemia orchitis in a patient on TNF-alpha inhibitor
Summary Purpose Tularemia represents a zoonotic infection that poses particular diagnostic and therapeutic challenges in immunocompromised patients. We present a rare case of tularemia orchitis in a patient receiving tumor necrosis factor alpha (TNF alpha) inhibitor treatment. Methods We conducted a case analysis of a 71-year-old farmer receiving adalimumab for psoriatic arthritis who developed sequential pulmonary and genitourinary manifestations of tularemia. Clinical presentation, laboratory findings, microbiological identification through culture and polymerase chain reaction testing, imaging studies, and histopathological examination were documented. Treatment response and clinical follow-up were monitored throughout the disease course. Results The patient initially presented with pneumonic tularemia confirmed by positive blood cultures. Following apparent clinical resolution with doxycycline therapy, he developed orchitis 3 months later requiring unilateral orchiectomy. Polymerase chain reaction testing confirmed Francisella tularensis as the causative pathogen in testicular tissue. Histological examination revealed dense inflammatory infiltration with histiocytes, neutrophils, and T‑lymphocytes. Combination therapy with doxycycline and ciprofloxacin achieved clinical remission, although fluoroquinolone-induced peripheral neuropathy necessitated treatment modification. Conclusion Patients receiving tumor necrosis factor alpha inhibitors demonstrate increased susceptibility to tularemia manifestations and potential disease relapse. The blood-testis barrier may limit antibiotic penetration, contributing to treatment failure with monotherapy. Enhanced clinical awareness and consideration of combination antimicrobial therapy may be warranted in immunocompromised patients with tularemia, particularly those residing in endemic regions.
- 13 July 2026
- Published by Springer Nature in Wiener klinische Wochenschrift
- p. 1-5
Pulmonary tularemia leading to a relapse of tularemia orchitis in a patient on TNF-alpha inhibitor
Summary Purpose Tularemia represents a zoonotic infection that poses particular diagnostic and therapeutic challenges in immunocompromised patients. We present a rare case of tularemia orchitis in a patient receiving tumor necrosis factor alpha (TNF alpha) inhibitor treatment. Methods We conducted a case analysis of a 71-year-old farmer receiving adalimumab for psoriatic arthritis who developed sequential pulmonary and genitourinary manifestations of tularemia. Clinical presentation, laboratory findings, microbiological identification through culture and polymerase chain reaction testing, imaging studies, and histopathological examination were documented. Treatment response and clinical follow-up were monitored throughout the disease course. Results The patient initially presented with pneumonic tularemia confirmed by positive blood cultures. Following apparent clinical resolution with doxycycline therapy, he developed orchitis 3 months later requiring unilateral orchiectomy. Polymerase chain reaction testing confirmed Francisella tularensis as the causative pathogen in testicular tissue. Histological examination revealed dense inflammatory infiltration with histiocytes, neutrophils, and T‑lymphocytes. Combination therapy with doxycycline and ciprofloxacin achieved clinical remission, although fluoroquinolone-induced peripheral neuropathy necessitated treatment modification. Conclusion Patients receiving tumor necrosis factor alpha inhibitors demonstrate increased susceptibility to tularemia manifestations and potential disease relapse. The blood-testis barrier may limit antibiotic penetration, contributing to treatment failure with monotherapy. Enhanced clinical awareness and consideration of combination antimicrobial therapy may be warranted in immunocompromised patients with tularemia, particularly those residing in endemic regions.
- Open Access
Histological aging signatures enable tissue-specific disease prediction from blood
Aging, the leading risk factor for numerous diseases, manifests through diverse structural and architectural changes in human tissues, providing an opportunity to quantify and interpret tissue-specific aging. To address this, we present a comprehensive assessment of tissue changes occurring during human aging, utilizing a vast array of whole slide histopathological images from the Genotype-Tissue Expression Project (GTEx), primarily reflecting non-diseased tissue samples. Using deep learning, we analyzed 25,712 images from 40 distinct tissue types across 983 individuals, quantifying nuanced morphological changes that tissues undergo with age. We developed ‘tissue clocks’—predictors of biological age based on tissue images—which achieved a mean prediction error of 4.9 years. These clocks were associated with established aging markers, including telomere attrition, subclinical pathologies, and comorbidities. In a systematic assessment of biological age rates across organs, we identified pervasive non-uniform rates of aging across the human lifespan, with some organs exhibiting earlier changes (20-40 years old) and others showing bimodal patterns of age-related changes. We also uncovered several associations between demographic, lifestyle, and medical history factors and tissue-specific acceleration or deceleration of biological age, highlighting potential modifiable risk factors that influenced the aging process at the tissue level. Finally, by combining paired histological images and gene expression data, we developed a strategy to predict tissue-specific age gaps from blood samples. This approach was validated in independent cohorts covering eight diseases, ranging from acute conditions like stroke to chronic diseases such as cystic fibrosis and Alzheimer’s disease. It successfully recovered significant associations with disease-relevant organs and revealed patterns of systemic and tissue-specific aging that may reflect broader physiological changes in health and disease. This work offers a new perspective on the aging process by positioning tissue structure as an integrator of cellular and molecular changes that reflect the physiological state of organs in health and disease. It underscores the value of histopathological imaging as a tool for understanding human aging and provides a foundation for the monitoring of tissue-specific aging processes in age-associated diseases.
Open AccessHistological aging signatures enable tissue-specific disease prediction from blood
Aging, the leading risk factor for numerous diseases, manifests through diverse structural and architectural changes in human tissues, providing an opportunity to quantify and interpret tissue-specific aging. To address this, we present a comprehensive assessment of tissue changes occurring during human aging, utilizing a vast array of whole slide histopathological images from the Genotype-Tissue Expression Project (GTEx), primarily reflecting non-diseased tissue samples. Using deep learning, we analyzed 25,712 images from 40 distinct tissue types across 983 individuals, quantifying nuanced morphological changes that tissues undergo with age. We developed ‘tissue clocks’—predictors of biological age based on tissue images—which achieved a mean prediction error of 4.9 years. These clocks were associated with established aging markers, including telomere attrition, subclinical pathologies, and comorbidities. In a systematic assessment of biological age rates across organs, we identified pervasive non-uniform rates of aging across the human lifespan, with some organs exhibiting earlier changes (20-40 years old) and others showing bimodal patterns of age-related changes. We also uncovered several associations between demographic, lifestyle, and medical history factors and tissue-specific acceleration or deceleration of biological age, highlighting potential modifiable risk factors that influenced the aging process at the tissue level. Finally, by combining paired histological images and gene expression data, we developed a strategy to predict tissue-specific age gaps from blood samples. This approach was validated in independent cohorts covering eight diseases, ranging from acute conditions like stroke to chronic diseases such as cystic fibrosis and Alzheimer’s disease. It successfully recovered significant associations with disease-relevant organs and revealed patterns of systemic and tissue-specific aging that may reflect broader physiological changes in health and disease. This work offers a new perspective on the aging process by positioning tissue structure as an integrator of cellular and molecular changes that reflect the physiological state of organs in health and disease. It underscores the value of histopathological imaging as a tool for understanding human aging and provides a foundation for the monitoring of tissue-specific aging processes in age-associated diseases.